Bilirubin (Total)
Total bilirubin measures the pigment produced when hemoglobin is broken down and processed by the liver for excretion in bile. Elevated levels cause jaundice and can result from hemolysis, Gilbert syndrome (a benign inherited variant), viral hepatitis, alcoholic or drug-induced liver injury, and bile duct obstruction. Fractionation into direct and indirect bilirubin narrows the cause.
Units: mg/dL; some labs report µmol/L (µmol/L = mg/dL × 17.1). Check the units on your report before comparing to any range here.
Optimal range: who says what
Institutions, researchers and practitioners draw the line in different places. Each position is listed with who holds it and, where a document states it, a link. How we verify ranges.
- Institution or studyUpper part of the normal rangeUK primary-care cohort of 504,206 adults (Horsfall et al. 2011, JAMA)Each 0.1 mg/dL higher bilirubin went with 8% (men) and 11% (women) lower lung cancer incidence and 3% lower mortality in men. Median bilirubin was 0.64 mg/dL in men and 0.53 in women
- Institution or studyMild Gilbert-range elevation is not harmfulVítek et al. 2002 (Atherosclerosis)Ischemic heart disease prevalence was 2% in people with Gilbert syndrome vs 12.1% in the general population
- Institution or study0.5-0.7 mg/dL (adults 60+)NHANES 1999-2004 (Ong et al. 2014, PLoS One)Against 0.5-0.7 mg/dL, adults 60 and older at 0.1-0.4 mg/dL had 1.36 times the mortality; 0.8 mg/dL or more trended higher but not significantly, so this cohort does not support the higher-is-better reading of Horsfall et al.
- Lab reference interval0.1-1.2 mg/dL (MedlinePlus)What a lab report flags against. A lab interval is not an optimal target.
20 of 21 itemized panels
Liver Function
What is Bilirubin (Total)?
Bilirubin is a yellow-orange pigment produced when red blood cells break down at the end of their 120-day lifespan. The spleen and liver process about 250-400 mg of bilirubin daily from old red blood cells. This bilirubin travels to the liver where it is processed (conjugated) and excreted into bile, eventually leaving the body through stool (giving stool its brown color).
Total bilirubin consists of two forms: indirect (unconjugated) bilirubin, which has not yet been processed by the liver, and direct (conjugated) bilirubin, which has been processed and is ready for excretion. When bilirubin accumulates in the blood above 2-3 mg/dL, it causes jaundice—yellowing of the skin and whites of the eyes. The pattern of elevation (direct vs indirect) helps diagnose the underlying cause.
While elevated bilirubin typically indicates liver disease, bile duct obstruction, or excessive red blood cell breakdown, mildly elevated indirect bilirubin can be beneficial. Gilbert's syndrome, a benign genetic condition causing mild bilirubin elevation, is associated with increased longevity and reduced cardiovascular disease, likely due to bilirubin's potent antioxidant properties. However, significantly elevated bilirubin requires medical evaluation.
Why Bilirubin Is Your Liver Excretion and Hemolysis Detector
- Jaundice detection: Bilirubin >2-3 mg/dL causes visible yellowing of skin/eyes, indicating liver dysfunction, bile duct obstruction, or hemolysis
- Differentiates liver disease types: Direct bilirubin elevation indicates cholestasis or hepatocellular damage; indirect elevation suggests hemolysis or Gilbert's syndrome
- Liver function assessment: Unlike ALT/AST which measure damage, bilirubin reflects liver's ability to process and excrete waste—a key synthetic function
- Hemolysis screening: Elevated indirect bilirubin with elevated LDH and low haptoglobin indicates red blood cell breakdown
- Prognostic indicator: In chronic liver disease, rising bilirubin predicts worse outcomes and need for transplant evaluation
- Potential health benefit: Mild elevation (Gilbert's syndrome) associated with lower cardiovascular risk due to antioxidant effects
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: Dose-Response Association Between Bilirubin and Cardiovascular Disease: A Systematic Review and Meta-analysis (Zuo et al., 2022); Association between plasma bilirubin and mortality (Vitek et al., 2019); Is serum total bilirubin a predictor of prognosis in arteriosclerotic cardiovascular disease? A meta-analysis (Lan et al., 2019). No single paper sets these cutoffs; for attributed targets see who says what.
Optimal0.3-1.0 mg/dL▼
- Normal bilirubin metabolism with healthy liver function and normal red blood cell turnover
- Values in this range indicate efficient bilirubin processing and excretion
- Most people fall in this range
Mildly Elevated (Often Gilbert's)1.0-3.0 mg/dL▼
- Often due to Gilbert's syndrome, a benign genetic condition affecting 3-7% of population
- If indirect bilirubin is elevated with normal liver enzymes, no jaundice, and normal hemolysis markers, this is typically Gilbert's and requires no treatment
- May actually be protective
- If direct bilirubin elevated or liver enzymes abnormal, investigate further
Moderately Elevated3.0-10.0 mg/dL▼
- Causes visible jaundice and indicates significant pathology
- Requires urgent investigation
- If direct bilirubin elevated: Evaluate for bile duct obstruction (gallstones, tumor, stricture), cholestatic liver disease, or hepatocellular damage
- Order liver enzymes, imaging (ultrasound/MRCP)
- If indirect bilirubin elevated: Investigate hemolysis (check LDH, haptoglobin, reticulocytes) or liver processing defect
Severely Elevated>10.0 mg/dL▼
- Indicates severe liver dysfunction, complete biliary obstruction, or massive hemolysis
- Requires immediate medical attention
- Levels >15-20 mg/dL suggest acute liver failure, complete bile duct obstruction, or severe hemolytic crisis
- Order urgent comprehensive workup including hepatitis panel, autoimmune markers, toxicology screen, imaging, and consider ICU-level care
- May require ERCP for obstruction or emergency interventions
What raises or lowers Bilirubin
Causes of high Bilirubin
- Elevated Direct (Conjugated) Bilirubin - Liver/Bile Duct Problems: Biliary obstruction (gallstones, pancreatic cancer, cholangiocarcinoma, strictures), Primary biliary cholangitis (autoimmune), Primary sclerosing cholangitis, Hepatitis (viral A/B/C, alcoholic, autoimmune, drug-induced), Cirrhosis and advanced liver disease, Dubin-Johnson syndrome (genetic, benign), Rotor syndrome (genetic, benign), Drug-induced cholestasis (antibiotics, oral contraceptives, anabolic steroids)
- Elevated Indirect (Unconjugated) Bilirubin - Hemolysis or Processing Defects: Gilbert's syndrome (genetic, benign, affects 3-7% of population), Crigler-Najjar syndrome (rare genetic disorder), Hemolytic anemia (autoimmune, hereditary spherocytosis, G6PD deficiency, sickle cell), Ineffective erythropoiesis (thalassemia, megaloblastic anemia), Mechanical hemolysis (prosthetic heart valves), Hematoma resorption (large bruise breaking down)
- Mixed Elevation: Severe hepatitis or acute liver failure, Sepsis, Cirrhosis with complications
Causes of low Bilirubin
- Chronic kidney disease (rare)
- Iron deficiency anemia
- Generally not clinically significant
Symptoms when Bilirubin is high or low
When high
- Jaundice: Yellowing of skin and whites of eyes (scleral icterus), usually visible when bilirubin >2-3 mg/dL
- Dark urine: Tea or cola-colored urine (if direct bilirubin elevated)
- Pale or clay-colored stools: If bile duct obstruction prevents bilirubin from reaching intestines
- Itching (pruritus): Can be severe and distressing, especially if cholestasis. Often worse at night
- Right upper quadrant pain: If gallstones or biliary obstruction
- Fatigue and weakness: Common with liver dysfunction or hemolysis
- Nausea and poor appetite: Especially if acute hepatitis or liver failure
- Confusion or altered mental status: If very high bilirubin (>20 mg/dL) with liver failure, indicates hepatic encephalopathy
Severity of symptoms correlates with bilirubin level. Mild elevation (1-3 mg/dL) often asymptomatic. Moderate elevation (3-10 mg/dL) causes noticeable jaundice. Severe elevation (>10 mg/dL) indicates serious disease requiring urgent care.
When low
- Low bilirubin (<0.2 mg/dL) is uncommon and generally not clinically significant.
- May be seen in chronic kidney disease but rarely indicates specific pathology.
- No symptoms associated with low bilirubin.
Low bilirubin requires no treatment and is not associated with adverse health outcomes.
How to move Bilirubin
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Address Bile Duct Obstruction (if Direct Bilirubin Elevated)
- Gallstone management: If obstruction from gallstones, may require ERCP to remove stones or cholecystectomy (gallbladder removal)
- Tumor evaluation: Pancreatic head tumors, cholangiocarcinoma, or metastases may require surgery, stenting, or oncologic therapy
- Primary sclerosing cholangitis: If chronic bile duct inflammation, ursodeoxycholic acid (UDCA) 13-15 mg/kg daily improves bile flow
- Drug-induced cholestasis: Discontinue offending medications (antibiotics, anabolic steroids, oral contraceptives)
- Supportive care: Cholestyramine 4g twice daily for severe itching if cholestasis present
Support Liver Function (if Hepatocellular Damage)
- Treat underlying cause: Alcohol cessation, antiviral therapy for hepatitis B/C, immunosuppression for autoimmune hepatitis
- N-acetylcysteine (NAC): 600-1200 mg daily supports glutathione synthesis and liver detoxification
- Milk thistle (silymarin): 140-280 mg 2-3x daily supports liver regeneration
- Avoid hepatotoxins: Eliminate alcohol, minimize acetaminophen (<2000 mg/day), avoid unnecessary medications
- Nutritional support: Adequate protein (1.2-1.5 g/kg), vitamins A/D/E/K supplementation if cholestasis present (fat-soluble vitamin malabsorption)
Address Hemolysis (if Indirect Bilirubin Elevated)
- Identify cause: Autoimmune hemolytic anemia, hemoglobinopathies (sickle cell, G6PD deficiency), mechanical hemolysis (prosthetic valves), medications
- Corticosteroids: Prednisone 0.5-1 mg/kg daily for autoimmune hemolytic anemia
- Folic acid: 1-5 mg daily if chronic hemolysis (supports red blood cell production)
- Avoid triggers: If G6PD deficiency, avoid fava beans, certain medications (sulfa drugs, antimalarials)
- Blood transfusions: If severe anemia from hemolysis causing symptoms
- Splenectomy: Consider if refractory autoimmune hemolysis
Gilbert's Syndrome Management (if Mild Indirect Elevation)
- No treatment needed: Gilbert's is benign and actually associated with health benefits (lower CV risk)
- Avoid fasting: Prolonged fasting (>12 hours) or caloric restriction can temporarily increase bilirubin
- Adequate hydration: Dehydration can increase bilirubin concentration
- Reduce stress: Physical or emotional stress can trigger transient increases
- Inform providers: Let doctors know about Gilbert's to avoid unnecessary testing during illnesses (infections often transiently increase bilirubin in Gilbert's)
- Consider it protective: Mild antioxidant benefit may reduce cardiovascular disease and cancer risk
Lifestyle and Supportive Measures
- Hydration: Adequate fluid intake (2-3 liters daily) supports bilirubin excretion
- Fiber intake: 25-35g daily fiber binds bile acids and supports elimination
- Probiotics: Lactobacillus and Bifidobacterium may help prevent deconjugation of bilirubin in gut
- Avoid alcohol: Completely abstain if liver disease present or bilirubin elevated
- Monitor for worsening: Track symptoms (jaundice intensity, dark urine, pale stools, itching) and seek care if worsening
- Vitamin supplementation: If cholestasis, supplement fat-soluble vitamins A, D, E, K
When to retest
- If mildly elevated (1-3 mg/dL) with normal liver enzymes: Likely Gilbert's syndrome. Retest after overnight fast (bilirubin will increase in Gilbert's) to confirm. No further monitoring needed if confirmed
- If moderately elevated (3-10 mg/dL): Urgent retest within 1-2 weeks with comprehensive panel (direct/indirect bilirubin, ALT, AST, ALP, GGT, albumin, PT/INR) and imaging
- If severely elevated (>10 mg/dL): Immediate hospitalization and workup. Monitor daily until improving
- After intervention: If treated for obstruction or hemolysis, retest within 48-72 hours to confirm improvement
- During liver disease: Monitor every 1-3 months depending on severity. Rising bilirubin in chronic liver disease suggests worsening function
- In pregnancy: Elevated bilirubin in third trimester may indicate intrahepatic cholestasis of pregnancy—monitor closely and consider early delivery if severe
Scientific Evidence
Gilbert's Syndrome and Heart Disease
Ischemic heart disease was found in 2% of 50 people with Gilbert syndrome over age 40, compared with 12.1% of the comparable general population. Bilirubin and total antioxidant capacity were higher in the Gilbert group.
Source: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels.
Bilirubin in the MELD Score
The MELD score combines serum bilirubin, creatinine, INR and the cause of liver disease. It predicted 3-month mortality with c-statistics of 0.78 to 0.87 across four patient groups and was proposed as the severity index for ranking liver transplant candidates.
Source: A model to predict survival in patients with end-stage liver disease.
Which Providers Test Bilirubin (Total)?
Cheapest: Oura Health Panels at $99/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
20 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $99 | 50 | $1.98 | |
| $190 | 100+ | $1.90 | |
| $250 | 65 | $3.85 | |
| $297 | 100+ | $2.97 | |
 Labcorp OnDemand | $338 | 50+ | $6.76 |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $895 | 100+ | $8.95 | |
| $996 | 59 | $16.88 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
1 itemized panel does not include Bilirubin (Total)
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer Bilirubin (Total). Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Experts discussing Bilirubin (Total)
Podcast episodes where clinicians and researchers cover this marker in depth. Curated by hand; an episode is listed only when the marker is a substantial topic, not a passing mention.
- The Best Diet to Reverse Fatty Liver DiseaseDisclosure: Hyman co-founded Function Health, which appears in our blood-test comparisons.
- #444 - Macrocytosis, Hemolytic Anemia, Myelodysplastic Syndrome
- What's the Deal with Liver Enzymes with Dr. William Carey MD
Frequently Asked Questions
What is the optimal range for Bilirubin (Total)?
Published positions differ: Upper part of the normal range (UK primary-care cohort of 504,206 adults (Horsfall et al. 2011, JAMA)); Mild Gilbert-range elevation is not harmful (Vítek et al. 2002 (Atherosclerosis)); 0.5-0.7 mg/dL (adults 60+) (NHANES 1999-2004 (Ong et al. 2014, PLoS One)). Lab reference interval: 0.1-1.2 mg/dL (MedlinePlus). That is what a lab report flags against, not an optimal target.
Which blood test providers include Bilirubin (Total)?
20 of the 21 blood testing panels we itemize marker by marker include Bilirubin (Total) in their panels. This biomarker is widely available across major providers.
Related: YouBoost rates lifestyle and supplement interventions by evidence.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025